Lexicon Genetics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

13.02.17	Lexicon To Present At The Leerink Partners 6th Annual Global Healthcare Conference (PR Newswire)
02.02.17	Research Reports Coverage on Biotech Stocks -- Anavex Life Sciences, Omeros, Spectrum Pharma, and Lexicon Pharma (PR Newswire)
26.01.17	Biotech Stocks Facing FDA Decision In February (RTTNews)
09.01.17	Lexicon Begins Phase 1 Clinical Trial Of Locally-acting SGLT1 Inhibitor, LX2761, For Potential Treatment Of Diabetes (PR Newswire)
27.12.16	Research Reports Initiation on Biotech Stocks -- Progenics Pharma, Tokai Pharma, Ophthotech, and Lexicon Pharma (PR Newswire)
21.12.16	Lexicon Reports Positive Top-line Results In Second Pivotal Phase 3 Study For Sotagliflozin In Patients With Type 1 Diabetes (PR Newswire)
05.12.16	Lexicon Reports Top-Line Results From Phase 2 Clinical Trial Conducted In Collaboration With JDRF (PR Newswire)
21.11.16	Lexicon Announces The Establishment Of The Commercial Leadership Team For Telotristat Ethyl (PR Newswire)
31.10.16	Do You Have These Biotech Stocks In Your Portfolio? (RTTNews)
26.10.16	OGXI Up On Phase II Results, DPRX Falters On Missed Steps, LXRX Awaits Dec Data (RTTNews)
15.09.16	Data Boosts AERI, FDA Panel Snubs SPPI, D-Day For ACRX Today, VTAE Abuzz (RTTNews)
12.09.16	Sweet Tidings For LXRX, CYAD To Report Data In Q4, D-Day For FOMX Today (RTTNews)
19.07.16	EVOK Runs Out Of Gas, ELOS Gets FDA Nod, 1 Down, 1 To Go For CYNA, BCLI Abuzz (RTTNews)
01.06.16	BMRN Pulls The Plug On DMD Drug, LXRX To Face FDA In Nov, TEVA Snubbed (RTTNews)
31.03.16	Be All EARS, DVAX Gets FDA Date, JAZZ Hits Right Notes, It's A No For OPK (RTTNews)
06.11.15	Sanofi, Lexicon Enter Collaboration And License Agreement For Sotagliflozin (RTTNews)
06.11.15	Sanofi And Lexicon Pharma To Collaborate On Sotagliflozin - Quick Facts (RTTNews)
03.08.15	Pre-market Movers For August 3 (FCAU, PRE, LXRX, TSN, ABGB) (RTTNews)
03.08.15	Lexicon's Phase III TELESTAR Study Meets Goals (RTTNews)
30.04.15	FLXN Gets Funded, LXRX Awaits Phase III Data, It's Decision Time For LuViva (RTTNews)
25.03.15	Lexicon Begins Screening In Phase 3 Trial Of Sotagliflozin For Type 1 Diabetes (RTTNews)
21.11.14	Lexicon Pharma Prices Public Offering Of $50.0 Mln Of Stock - Quick Facts (RTTNews)
22.10.14	Lexicon Signs Up To $145 Mln Licensing Deal With Ipsen For Carcinoid Drug (RTTNews)
09.07.14	JDRF To Fund Lexicon's Phase 2 Trial For Diabetes Drug LX4211 - Quick Facts (RTTNews)
07.07.14	Lexicon Pharma Appoints Lonnel Coats As CEO - Quick Facts (RTTNews)
14.04.14	Lexicon Announces Positive Results In Phase 2 Trial Of LX4211 In Type 1 Diabetes (RTTNews)
03.12.13	Lexicon Completes Phase 2 Trial Of LX1033 In IBS-d - Quick Facts (RTTNews)
09.10.13	Pre-market Movers For Oct 9 (AA, MW, JOSB, FDO, ARIA, LXRX, ICPT, FAST) (RTTNews)
09.10.13	Lexicon Reports Results From Study Of Telotristat Etiprate In Ulcerative Colitis (RTTNews)
09.10.13	Lexicon Completes Pilot Study Of Telotristat Etiprate In Ulcerative Colitis (PR Newswire)
04.10.13	Positive Results, Close of Public Offerings, Grants, Data Presentations and Partnerships - Research Report on Lexicon, Sangamo Biosciences, Immunomedics, NewLink Genetics, and Pacific Biosciences (PR Newswire)
01.10.13	Pre-market Movers For Oct 1 (MRK, NFLX, LXRX, MYGN, WAG, OLED) (RTTNews)
01.10.13	Lexicon Says LX4211 Meets Primary Endpoint In Study Of Type 2 Diabetes Patients (RTTNews)
01.10.13	LX4211 Achieves Positive Results in Type 2 Diabetes Patients with Renal Impairment (PR Newswire)
06.09.13	Lexicon To Present At The Stifel Nicolaus Healthcare Conference (PR Newswire)
05.09.13	Lexicon To Present At The Morgan Stanley Global Healthcare Conference (PR Newswire)
07.08.13	Lexicon To Present At The Wedbush PacGrow Life Sciences Management Access Conference (PR Newswire)
31.07.13	AEGR Nearing $100, ALXA Grows Richer, CBST's Deal Day, BEAT Hits Right Notes (RTTNews)
30.07.13	Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2013 Second Quarter Financial Results (PR Newswire)
23.07.13	Lexicon to Report Second Quarter Financial Results on July 30, 2013 (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Givaudan	4’059.00	2.92 %	K V
Logitech Intl	94.36	2.03 %	K V
Part Grp Hldg	1’422.50	1.07 %	K V
Sika	242.10	0.71 %	K V
Holcim	98.62	0.39 %	K V
Roche Hldg G	294.50	-1.11 %	K V
Kuehne+Nagel Int	209.20	-1.13 %	K V
Nestle	82.48	-1.43 %	K V
Swisscom	499.80	-2.00 %	K V
Novartis	95.37	-2.46 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Lexicon Genetics Inc.

Aktien Top/Flop

Meistgelesene Nachrichten